Panel Discussion: Defining Biomarker Context of Use in Early on to Ensure Valuable Insights from Clinical Implementation into Neurology Trials

Time: 3:45 pm
day: Conference Day One

Details:

Critically evaluating correct and valuable applications of biomarkers for meaningful and actionable insights: target

engagement, patient stratification, diagnosis, prognosis and predicting patient outcome

• Addressing regulatory requirements and validation processes necessary for biomarkers in clinical trials and discuss

strategies for robust biomarker validation to ensure reliability and reproducibility of results across different patient

populations and trial phases

• Integrating biomarkers into clinical workflow for neurological trials, including sample collection, processing, analysis and

the need for standardized protocols

• Ensuring seamless communication between research and clinical teams to maximize utility and impact of biomarkers in a

areal world setting

Speakers: